8-KRegulation FD

QUEST DIAGNOSTICS INC 8-K Report, Regulation FD Disclosure (Sep 5, 2017)

Filed September 5, 2017For Securities:DGX

Summary

Quest Diagnostics Inc. (DGX) filed an 8-K on September 5, 2017, to disclose a change in its principal executive offices. Effective September 1, 2017, the company's primary operational headquarters moved to 500 Plaza Drive, Secaucus, New Jersey 07094. This move is significant as it will be the new point of contact for shareholder proposals intended for the 2018 annual meeting, as well as the location from which investors can obtain the 2016 Annual Report on Form 10-K.

Key Highlights

  • 1Quest Diagnostics has relocated its principal executive offices.
  • 2The new address is 500 Plaza Drive, Secaucus, New Jersey 07094.
  • 3This change became effective on September 1, 2017.
  • 4The new location will serve as the contact point for shareholder proposals for the 2018 annual meeting.
  • 5Investor Relations and copies of the 2016 10-K will be available at the new address.

Frequently Asked Questions

The primary purpose of this 8-K filing is to inform investors and stakeholders about the relocation of Quest Diagnostics' principal executive offices.

The change in principal executive offices became effective as of September 1, 2017.

The new principal executive offices are located at 500 Plaza Drive, Secaucus, New Jersey 07094.

Shareholder proposals intended for the 2018 annual meeting should now be sent to the Corporate Secretary at the new Secaucus, New Jersey address. Additionally, copies of the 2016 Annual Report on Form 10-K can be obtained from Investor Relations at this new location.